Home / post pandemic
COVID-Adjacent drug development, post-pandemic gets a boost in areas such as ACE2 receptor and cancer therapeutics. Biodextris and the Clean Biologics group assist sponsors from process and analytical development to GMP manufacturing.
By submitting this contact form, I accept that the information entered will be used as part of my demand.
To know and exercise your rights, in particular the right to withdraw your consent to the use of the data collected by this form, please consult the general conditions of use related to the management of personal data.